{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:31:51Z","timestamp":1785461511314,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1741-7015-11-183","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T10:42:48Z","timestamp":1376563368000},"source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)"],"prefix":"10.1186","volume":"11","author":[{"given":"Jun-ichi","family":"Kira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"1091_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ana.410210203","volume":"21","author":"M Osame","year":"1987","unstructured":"Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A: Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and T-cell leukemia-like cells. Ann Neurol. 1987, 21: 117-122.","journal-title":"Ann Neurol"},{"key":"1091_CR2","first-page":"100","volume":"18","author":"S Izumo","year":"2010","unstructured":"Izumo S: Neuropathology of HTLV-1-associated myelopathy (HAM). Neuropathology. 2010, 18: 100-112.","journal-title":"Neuropathology"},{"key":"1091_CR3","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.38.8.1302","volume":"38","author":"Y Itoyama","year":"1988","unstructured":"Itoyama Y, Minato S, Kira J, Goto I, Sato H, Okochi K, Yamamoto N: Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology. 1988, 38: 1302-1307.","journal-title":"Neurology"},{"key":"1091_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/00005072-199411000-00009","volume":"53","author":"F Umehara","year":"1994","unstructured":"Umehara F, Nakamura A, Izumo S, Kubota R, Ijichi S, Kashio N, Hashimoto K, Usuku K, Sato E, Osame M: Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol. 1994, 53: 617-624.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1091_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.410290214","volume":"29","author":"J Kira","year":"1991","unstructured":"Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y: Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol. 1991, 29: 194-201.","journal-title":"Ann Neurol"},{"key":"1091_CR6","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.4049\/jimmunol.178.9.5966","volume":"178","author":"R Kubota","year":"2007","unstructured":"Kubota R, Hanada K, Furukawa Y, Arimura K, Osame M, Gojobori T, Izumo S: Genetic stability of human T lymphotropic virus type I despite of antiviral pressures by CTLs. J Immunol. 2007, 178: 5966-5972.","journal-title":"J Immunol"},{"key":"1091_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-510X(96)05319-1","volume":"147","author":"Y Yamasaki","year":"1997","unstructured":"Yamasaki Y, Kira J, Koyanagi Y, Kawano Y, Miyano-Kurosaki N, Nakamura M, Baba E, Suzuki J, Yamamoto A, Yamamoto N, Kobayashi T: Long term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy\/tropical spastic paraparesis: a combined clinical, virological and immunological study. J Neurol Sci. 1997, 147: 135-144.","journal-title":"J Neurol Sci"},{"key":"1091_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(88)90525-9","volume":"2","author":"H Matsuo","year":"1988","unstructured":"Matsuo H, Nakamura T, Tsujihara M, Kinoshita I, Satoh A, Tomita I, Shirabe S, Shibayama K, Nagataki S: Plasmaphersis in treatment of human T-lymphotropic virus type-I associated myelopathy. Lancet. 1988, 2: 1109-1113.","journal-title":"Lancet"},{"key":"1091_CR9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/jnnp.56.11.1213","volume":"56","author":"A Kataoka","year":"1993","unstructured":"Kataoka A, Iami H, Inayoshi S, Tsuda T: Intermittent high-dose vitamin C therapy in patients with HTLV-1 associated myelopathy. J Neurol Neurosurg Psychiatry. 1993, 56: 1213-1216.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1091_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/13550289609146899","volume":"2","author":"M Nakagawa","year":"1996","unstructured":"Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H, Izumo S, Arimura K, Osame M: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Neurovirol. 1996, 2: 345-355.","journal-title":"J Neurovirol"},{"key":"1091_CR11","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Cameiro-Proietti AB, Catalan-Soares BC, Murphy EL: Global epidemiology of HTLV-I infection and associated disease. Oncogene. 2005, 24: 6058-6068.","journal-title":"Oncogene"},{"key":"1091_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/135965350901400412","volume":"14","author":"Y Nishiura","year":"2009","unstructured":"Nishiura Y, Nakamura T, Fukushima N, Nakamura H, Ida H, Aramaki T, Eguchi K: Disulfide-mediated apoptosis of human T-lymphotropic virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. Antivir Ther. 2009, 14: 533-542.","journal-title":"Antivir Ther"},{"key":"1091_CR13","unstructured":"Nakamura T, Matsuo T, Fukuda T, Yamato S, Yamaguchi K, Kinoshita I, Matsuzaki T, Nishiura Y, Nagasato K, Narita-Masuda T, Nakamura H, Satoh K, Sasaki H, Kawakami A: Efficacy of propfultiamine treatment in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis: results from an open-label clinical trial. BMC Med. In press"},{"key":"1091_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1742-4690-3-63","volume":"3","author":"GP Taylor","year":"2006","unstructured":"Taylor GP, Goon P, Furukawa Y, Green H, Barfield A, Mosley A, Nose H, Babiker A, Rudge P, Usuku K, Osame M, Bangham CRM, Weber JN: Zidovudine plus lamivudine in human T-lymphotropic virus type-1-associated myelopathy: a randomized trial. Retrovirology. 2006, 3: 63.","journal-title":"Retrovirology"},{"key":"1091_CR15","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1182\/blood-2011-04-349910","volume":"118","author":"S Olindo","year":"2011","unstructured":"Olindo S, Belrose G, Gillet N, Rodriguez S, Boxus M, Verlaeten O, Asquith B, Bangham C, Signat\u00e9 A, Smadja D, Lezin A, C\u00e9saire R, Willems L: Safety of long-term treatment of HAM\/TSP patients with valproic acid. Blood. 2011, 118: 6306-6309.","journal-title":"Blood"},{"key":"1091_CR16","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1212\/01.wnl.0000326589.57128.c3","volume":"71","author":"M Tanaka","year":"2008","unstructured":"Tanaka M, Matsushita T, Tateishi T, Ochi H, Kawano Y, Mei F-J, Minohara M, Murai H, Kira J: Distinct CSF cytokine\/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology. 2008, 71: 974-981.","journal-title":"Neurology"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-11-183\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-11-183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T21:33:43Z","timestamp":1688420023000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-11-183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-11-183","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]},"article-number":"183"}}